0000939767-20-000083.txt : 20200515 0000939767-20-000083.hdr.sgml : 20200515 20200515202049 ACCESSION NUMBER: 0000939767-20-000083 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200513 FILED AS OF DATE: 20200515 DATE AS OF CHANGE: 20200515 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hessekiel Jeffrey CENTRAL INDEX KEY: 0001599803 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30235 FILM NUMBER: 20887472 MAIL ADDRESS: STREET 1: 210 EAST GRAND AVE. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EXELIXIS, INC. CENTRAL INDEX KEY: 0000939767 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 043257395 STATE OF INCORPORATION: DE FISCAL YEAR END: 0101 BUSINESS ADDRESS: STREET 1: 1851 HARBOR BAY PARKWAY CITY: ALAMEDA STATE: CA ZIP: 94502 BUSINESS PHONE: 6508377000 MAIL ADDRESS: STREET 1: 1851 HARBOR BAY PARKWAY CITY: ALAMEDA STATE: CA ZIP: 94502 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS INC DATE OF NAME CHANGE: 20000207 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20000106 4 1 wf-form4_158958843032722.xml FORM 4 X0306 4 2020-05-13 0 0000939767 EXELIXIS, INC. EXEL 0001599803 Hessekiel Jeffrey C/O EXELIXIS, INC. 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 0 1 0 0 EVP and General Counsel Common Stock 2020-05-13 4 M 0 25000 1.70 A 264188 D Common Stock 2020-05-13 4 F 0 13875 26.53 D 250313 D Common Stock 999 I By 401(k) Option (right to buy) 1.7 2020-05-13 4 M 0 25000 0 D 2015-07-20 2021-09-18 Common Stock 25000.0 0 D Includes 36,559 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units. Represents a "net exercise" of an outstanding stock option. The Reporting Person received 11,125 shares of Common Stock on the net exercise of a stock option to purchase 25,000 shares of Common Stock. The Issuer withheld 13,875 shares of Common Stock underlying the stock option for payment of the exercise price and tax withholding using a stock price on May 13, 2020 of $26.53. Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of May 13, 2020. The option, representing the right to purchase a total of 400,000 shares of Common Stock, became fully exercisable on April 28, 2016. /s/ Jennifer Drimmer Rokovich, Attorney in Fact 2020-05-15